NovaBridge Biosciences files initial beneficial ownership statement for CFO Charles Silberstein
NBP•Chief Financial Officer Charles Silberstein filed an initial beneficial ownership statement dated November 2, 2026.
1. Ownership filing
NovaBridge Biosciences Chief Financial Officer Charles Silberstein filed an initial statement of beneficial ownership dated November 2, 2026.
